AIxCrypto Holdings, Inc. (AIXC): Nasdaq/NYSE listing notice — Qualigen gets final Nasdaq extension to prove equity compliance by Nov 15 after negative equity

AIxCrypto Holdings, Inc.

Nasdaq Panel granted final exception to demonstrate compliance with $2.5M equity rule by Nov 15, 2025; no further extensions.
As of June 30, 2025, stockholders' equity was approximately negative $1.6 million, failing the requirement.
Company completed $4.3M Series A-3 Preferred private placement on July 28, but Panel excluded it from July 28 compliance date.
Amendment to Marizyme promissory note reduced collateral charge, increasing equity by over $600,000.
Company is current on SEC filings and regained compliance with Nasdaq Periodic Filing Rule.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

AIxCrypto Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

September 4, 2025, Qualigen Therapeutics, Inc. (the “Company”) received a written decision (the “Decision Letter”) from the Nasdaq Hearings Panel (the “Panel”) in response to the Company’s August 19, 2025 update and request for a compliance determination with respect to the Panel’s July 24, 2025 decision, as amended. As previously disclosed, on July 24, 2025, the Panel granted the Company an exception to remain listed on The Nasdaq Capital Market, conditioned on demonstrating compliance with Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”), which requires companies to maintain stockholders’

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AIxCrypto Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-026864

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.